CME Group (CME) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CME Stock Forecast

CME Group stock forecast is as follows: an average price target of $217.06 (represents a -5.49% downside from CME’s last price of $229.66) and a rating consensus of 'Hold', based on 15 wall street analysts offering a 1-year stock forecast.

CME Price Target

The average price target for CME Group (CME) is $217.06 based on 1-year price targets from 15 Wall Street analysts in the past 3 months, with a price target range of $258.00 to $151.00. This represents a potential -5.49% downside from CME's last price of $229.66.

CME Analyst Ratings

Hold

According to 15 Wall Street analysts, CME Group's rating consensus is 'Hold'. The analyst rating breakdown for CME stock is 0 'Strong Buy' (0.00%), 5 'Buy' (33.33%), 8 'Hold' (53.33%), 2 'Sell' (13.33%), and 0 'Strong Sell' (0.00%).

CME Group Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 24, 2024	Owen Lau	Oppenheimer	$258.00	$227.43	13.44%	12.34%
Oct 24, 2024	Benjamin Budish	Barclays	$231.00	$227.14	1.70%	0.58%
Oct 03, 2024	Christopher Allen	Citigroup	$250.00	$223.57	11.82%	8.86%
Sep 26, 2024	Ashish Sabadra	RBC Capital	$235.00	$218.47	7.57%	2.33%
Sep 03, 2024	Craig Siegenthaler	Bank of America Securities	$177.00	$215.74	-17.96%	-22.93%
Jul 25, 2024	Brian Bedell	Deutsche Bank	$193.00	$198.92	-2.98%	-15.96%
Jul 25, 2024	Patrick Moley	Piper Sandler	$225.00	$199.38	12.85%	-2.03%
Jul 25, 2024	Benjamin Budish	Barclays	$209.00	$197.25	5.96%	-9.00%
Jun 05, 2024	Alex Kromm	UBS	$250.00	$203.78	22.68%	8.86%
Apr 25, 2024	Andrew Bond	Rosenblatt Securities	$187.00	$212.59	-12.04%	-18.58%

Row per page

Go to

The latest CME Group stock forecast, released on Oct 24, 2024 by Owen Lau from Oppenheimer, set a price target of $258.00, which represents a 13.44% increase from the stock price at the time of the forecast ($227.43), and a 12.34% increase from CME last price ($229.66).

CME Group Price Target by Period

	1M	3M	12M
# Anlaysts	2	5	12
Avg Price Target	$244.50	$230.20	$221.08
Last Closing Price	$229.66	$229.66	$229.66
Upside/Downside	6.46%	0.24%	-3.74%

In the current month, the average price target of CME Group stock is $244.50, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 6.46% increase as opposed to CME Group's last price of $229.66. This month's average price target is up 6.21% compared to last quarter, and up 10.59% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 24, 2024	Citigroup	Buy	Buy	Hold
Oct 17, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
Oct 14, 2024	Oppenheimer	Outperform	Outperform	Hold
Oct 08, 2024	Piper Sandler	Overweight	Overweight	Hold
Oct 07, 2024	Barclays	Equal-Weight	Equal-Weight	Hold
Oct 03, 2024	Goldman Sachs	Sell	Sell	Hold
Oct 03, 2024	Citigroup	Buy	Buy	Hold
Sep 26, 2024	RBC Capital	-	Sector Perform	Initialise
Sep 25, 2024	Cowen & Co.	-	Hold	Initialise
Sep 05, 2024	Citigroup	Buy	Buy	Hold

Row per page

Go to

CME Group's last stock rating was published by Citigroup on Oct 24, 2024. The company gave CME a "Buy" rating, the same as its previous rate.

CME Group Financial Forecast

CME Group Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.44B	$1.34B	$1.36B	$1.44B	$1.21B	$1.23B	$1.24B	$1.35B	$1.15B	$1.11B	$1.18B	$1.25B	$1.10B	$1.08B
Avg Forecast	$1.70B	$1.71B	$1.70B	$1.67B	$1.66B	$1.67B	$1.63B	$1.62B	$1.58B	$1.60B	$1.55B	$1.53B	$1.52B	$1.59B	$1.53B	$1.48B	$1.43B	$1.34B	$1.34B	$1.41B	$1.21B	$1.22B	$1.25B	$1.33B	$1.17B	$1.15B	$1.17B	$1.26B	$1.10B	$1.09B
High Forecast	$1.76B	$1.78B	$1.77B	$1.73B	$1.72B	$1.74B	$1.69B	$1.69B	$1.64B	$1.66B	$1.61B	$1.58B	$1.57B	$1.64B	$1.53B	$1.48B	$1.44B	$1.36B	$1.39B	$1.47B	$1.26B	$1.22B	$1.25B	$1.33B	$1.17B	$1.15B	$1.17B	$1.26B	$1.10B	$1.09B
Low Forecast	$1.63B	$1.64B	$1.63B	$1.59B	$1.59B	$1.60B	$1.56B	$1.55B	$1.51B	$1.53B	$1.49B	$1.50B	$1.48B	$1.53B	$1.53B	$1.48B	$1.41B	$1.33B	$1.28B	$1.35B	$1.16B	$1.22B	$1.25B	$1.33B	$1.17B	$1.15B	$1.17B	$1.26B	$1.10B	$1.09B
# Analysts	6	3	3	3	3	3	4	5	4	5	2	7	8	4	5	4	8	11	5	9	5	4	4	7	5	5	10	7	5	7
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.01%	1.00%	1.01%	1.02%	1.00%	1.01%	0.99%	1.02%	0.98%	0.97%	1.01%	0.99%	1.00%	0.99%

CME Group's average Quarter revenue forecast for Mar 24 based on 4 analysts is $1.48B, with a low forecast of $1.48B, and a high forecast of $1.48B. CME's average Quarter revenue forecast represents a 2.56% increase compared to the company's last Quarter revenue of $1.44B (Dec 23).

CME Group EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	3	3	3	3	3	4	5	4	5	2	7	8	4	5	4	8	11	5	9	5	4	4	7	5	5	10	7	5	7
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$949.50M	$-170.30M	$-422.30M	$1.00B	$745.70M	$828.80M	$839.80M	$951.00M	$867.90M	$1.09B	$801.90M	$861.10M	$666.10M	$672.60M
Avg Forecast	$1.11B	$1.12B	$1.11B	$1.09B	$1.08B	$1.10B	$1.07B	$1.06B	$1.03B	$1.05B	$1.02B	$1.00B	$996.09M	$1.04B	$1.00B	$1.20B	$934.81M	$878.16M	$877.34M	$1.09B	$1.02B	$741.92M	$756.86M	$992.91M	$710.13M	$695.91M	$712.55M	$871.22M	$667.79M	$664.75M
High Forecast	$1.15B	$1.16B	$1.16B	$1.13B	$1.13B	$1.14B	$1.11B	$1.10B	$1.07B	$1.09B	$1.06B	$1.03B	$1.03B	$1.08B	$1.00B	$1.44B	$941.35M	$886.95M	$911.81M	$1.31B	$1.22B	$741.92M	$756.86M	$1.19B	$710.13M	$695.91M	$712.55M	$1.05B	$667.79M	$664.75M
Low Forecast	$1.06B	$1.07B	$1.07B	$1.04B	$1.04B	$1.05B	$1.02B	$1.02B	$988.17M	$1.00B	$972.62M	$983.38M	$970.05M	$1.00B	$1.00B	$961.14M	$921.74M	$869.15M	$840.29M	$873.76M	$813.37M	$741.92M	$756.86M	$794.33M	$710.13M	$695.91M	$712.55M	$696.98M	$667.79M	$664.75M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	-0.19%	-0.48%	0.92%	0.73%	1.12%	1.11%	0.96%	1.22%	1.56%	1.13%	0.99%	1.00%	1.01%

4 analysts predict CME's average Quarter EBITDA for Mar 24 to be $1.20B, with a high of $1.44B and a low of $961.14M. This is 26.53% upper than CME Group's previous annual EBITDA (Dec 23) of $949.50M.

CME Group Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	3	3	3	3	3	4	5	4	5	2	7	8	4	5	4	8	11	5	9	5	4	4	7	5	5	10	7	5	7
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$804.30M	$750.20M	$777.60M	$883.80M	$637.90M	$679.60M	$662.50M	$711.00M	$625.20M	$926.50M	$510.30M	$574.40M	$424.00M	$411.70M
Avg Forecast	$1.05B	$1.07B	$1.08B	$1.05B	$945.34M	$978.79M	$966.25M	$962.59M	$907.67M	$952.64M	$925.66M	$918.65M	$886.08M	$954.79M	$911.93M	$812.99M	$821.71M	$800.16M	$792.32M	$739.08M	$679.33M	$697.88M	$696.14M	$671.89M	$590.18M	$558.34M	$578.39M	$561.27M	$490.94M	$507.43M
High Forecast	$1.10B	$1.12B	$1.14B	$1.10B	$993.63M	$1.03B	$1.02B	$1.01B	$954.04M	$1.00B	$972.95M	$954.25M	$928.79M	$997.85M	$911.98M	$975.59M	$843.43M	$818.18M	$832.79M	$886.90M	$815.20M	$697.88M	$696.14M	$806.27M	$590.18M	$558.34M	$578.39M	$673.53M	$490.94M	$507.43M
Low Forecast	$993.47M	$1.01B	$1.02B	$990.07M	$893.45M	$925.06M	$913.21M	$909.75M	$857.85M	$900.35M	$874.85M	$897.28M	$846.94M	$911.72M	$911.89M	$650.39M	$807.23M	$785.74M	$748.83M	$591.27M	$543.47M	$697.88M	$696.14M	$537.52M	$590.18M	$558.34M	$578.39M	$449.02M	$490.94M	$507.43M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.98%	0.94%	0.98%	1.20%	0.94%	0.97%	0.95%	1.06%	1.06%	1.66%	0.88%	1.02%	0.86%	0.81%

CME Group's average Quarter net income forecast for Mar 24 is $812.99M, with a range of $650.39M to $975.59M. CME's average Quarter net income forecast represents a 1.08% increase compared to the company's last Quarter net income of $804.30M (Dec 23).

CME Group SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	3	3	3	3	3	4	5	4	5	2	7	8	4	5	4	8	11	5	9	5	4	4	7	5	5	10	7	5	7
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$32.20M	$37.80M	$38.30M	$38.50M	$35.10M	$32.00M	$31.80M	$138.50M	$152.10M	$140.30M	$150.30M	$161.50M	$154.20M
Avg Forecast	$54.49M	$54.87M	$54.58M	$53.46M	$53.14M	$53.72M	$52.36M	$52.08M	$50.62M	$51.33M	$49.82M	$49.19M	$48.87M	$51.01M	$49.23M	$181.35M	$45.86M	$43.08M	$43.04M	$164.86M	$150.49M	$39.21M	$40.00M	$149.88M	$37.53M	$36.78M	$37.66M	$146.86M	$35.29M	$35.13M
High Forecast	$56.63M	$57.03M	$56.73M	$55.56M	$55.23M	$55.83M	$54.42M	$54.13M	$52.60M	$53.35M	$51.78M	$50.77M	$50.46M	$52.80M	$49.23M	$217.62M	$46.18M	$43.51M	$44.73M	$197.84M	$180.59M	$39.21M	$40.00M	$179.85M	$37.53M	$36.78M	$37.66M	$176.24M	$35.29M	$35.13M
Low Forecast	$52.19M	$52.56M	$52.28M	$51.20M	$50.90M	$51.45M	$50.15M	$49.88M	$48.48M	$49.17M	$47.72M	$48.24M	$47.59M	$49.22M	$49.23M	$145.08M	$45.22M	$42.64M	$41.22M	$131.89M	$120.39M	$39.21M	$40.00M	$119.90M	$37.53M	$36.78M	$37.66M	$117.49M	$35.29M	$35.13M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.75%	0.88%	0.23%	0.26%	0.90%	0.80%	0.21%	3.69%	4.14%	3.73%	1.02%	4.58%	4.39%

CME Group's average Quarter SG&A projection for Dec 23 is $45.86M, based on 8 Wall Street analysts, with a range of $45.22M to $46.18M. The forecast indicates a 42.42% rise compared to CME last annual SG&A of $32.20M (Sep 23).

CME Group EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
# Analysts	6	3	3	3	3	3	4	5	4	5	2	7	8	4	5	4	8	11	5	9	5	4	4	7	5	5	10	7	5	7
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.24	$2.06	$2.14	$2.46	$1.76	$1.87	$1.82	$1.96	$1.74	$2.59	$1.42	$1.60	$1.18	$1.15
Avg Forecast	$2.92	$2.97	$3.01	$2.91	$2.63	$2.72	$2.68	$2.67	$2.52	$2.65	$2.57	$2.55	$2.46	$2.65	$2.53	$2.45	$2.28	$2.22	$2.20	$2.37	$1.88	$1.94	$1.93	$2.00	$1.64	$1.55	$1.61	$1.76	$1.36	$1.41
High Forecast	$3.07	$3.12	$3.16	$3.06	$2.76	$2.86	$2.82	$2.81	$2.65	$2.78	$2.70	$2.65	$2.58	$2.77	$2.53	$2.45	$2.34	$2.27	$2.31	$2.50	$1.92	$1.94	$1.93	$2.00	$1.64	$1.55	$1.61	$1.76	$1.36	$1.41
Low Forecast	$2.76	$2.81	$2.84	$2.75	$2.48	$2.57	$2.54	$2.53	$2.38	$2.50	$2.43	$2.49	$2.35	$2.53	$2.53	$2.45	$2.24	$2.18	$2.08	$2.24	$1.85	$1.94	$1.93	$2.00	$1.64	$1.55	$1.61	$1.76	$1.36	$1.41
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.98%	0.93%	0.97%	1.04%	0.94%	0.96%	0.94%	0.98%	1.06%	1.67%	0.88%	0.91%	0.86%	0.82%

According to 4 Wall Street analysts, CME Group's projected average Quarter EPS for Mar 24 is $2.45, with a low estimate of $2.45 and a high estimate of $2.45. This represents a 9.43% increase compared to CME previous annual EPS of $2.24 (Dec 23).

CME Group Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SPGI	S&P Global	$502.31	$512.75	2.08%	Buy
MORN	Morningstar	$334.88	$340.00	1.53%	Buy
MSCI	MSCI	$597.13	$604.55	1.24%	Buy
CME	CME Group	$229.66	$217.06	-5.49%	Hold
ICE	Intercontinental Exchange	$157.93	$148.41	-6.03%	Buy
MCO	Moody's	$468.78	$418.50	-10.73%	Buy
NDAQ	Nasdaq	$80.16	$71.48	-10.83%	Buy

CME Forecast FAQ

Is CME Group a good buy?

No, according to 15 Wall Street analysts, CME Group (CME) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 33.33% of CME's total ratings.

What is CME's price target?

CME Group (CME) average price target is $217.06 with a range of $151 to $258, implying a -5.49% from its last price of $229.66. The data is based on 15 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CME Group stock go up soon?

According to Wall Street analysts' prediction for CME stock, the company can go down by -5.49% (from the last price of $229.66 to the average price target of $217.06), up by 12.34% based on the highest stock price target, and down by -34.25% based on the lowest stock price target.

Can CME Group stock reach $300?

CME's average twelve months analyst stock price target of $217.06 does not support the claim that CME Group can reach $300 in the near future.

What is CME Group's current price target trend?

2 Wall Street analysts forecast a $244.5 price target for CME Group (CME) this month, up 6.46% from its last price of $229.66. Compared to the last 3 and 12 months, the average price target increased by 0.24% and decreased by -3.74%, respectively.

What are CME Group's analysts' financial forecasts?

CME Group's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $6.58B (high $6.84B, low $6.3B), average EBITDA is $4.31B (high $4.48B, low $4.13B), average net income is $3.85B (high $4.05B, low $3.64B), average SG&A $211.31M (high $219.61M, low $202.39M), and average EPS is $10.7 (high $11.25, low $10.12). CME's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $6.77B (high $7.04B, low $6.49B), average EBITDA is $4.43B (high $4.61B, low $4.24B), average net income is $4.25B (high $4.47B, low $4.02B), average SG&A $217.4M (high $225.95M, low $208.22M), and average EPS is $11.81 (high $12.41, low $11.16).

Did the CME's actual financial results beat the analysts' financial forecasts?

Based on CME Group's last annual report (Dec 2023), the company's revenue was $5.58B, beating the average analysts forecast of $5.52B by 1.02%. Apple's EBITDA was $3.79B, beating the average prediction of $3.78B by 0.15%. The company's net income was $3.19B, beating the average estimation of $3.15B by 1.03%. Apple's SG&A was $144.4M, missing the average forecast of $296.85M by -51.36%. Lastly, the company's EPS was $8.86, missing the average prediction of $9.08 by -2.43%. In terms of the last quarterly report (Dec 2023), CME Group's revenue was $1.44B, beating the average analysts' forecast of $1.43B by 0.77%. The company's EBITDA was $949.5M, beating the average prediction of $934.81M by 1.57%. CME Group's net income was $804.3M, missing the average estimation of $821.71M by -2.12%. The company's SG&A was $0, missing the average forecast of $45.86M by -100.00%. Lastly, the company's EPS was $2.24, missing the average prediction of $2.28 by -1.87%